Lela Buckingham

Reversal of Multidrug-Resistance Phenotype by Surfactants: Relationship to Membrane Lipid Fluidity

Pradeep K. Dudeja, K.M. Anderson, Jack Harris et al. · Archives of Biochemistry and Biophysics · 1995 · 140 citations

Lipid Preparation, Proteinlipid Interaction, Engineering +11

Approximate dimensions of membrane lesions produced by streptolysin S and streptolysin O

Lela Buckingham, James L. Duncan · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1983 · 104 citations

Membrane Lesions, Streptolysin O, Biochemistry +7

Nucleotide sequence and promoter analysis of SPO13, a meiosis-specific gene of Saccharomyces cerevisiae.

Lela Buckingham, H T Wang, Robert T. Elder et al. · Proceedings of the National Academy of Sciences · 1990 · 101 citations · Full text

Promoter Analysis, Genetics, Genomic Mechanism +22

<i>PTEN, RASSF1</i> and <i>DAPK</i> site‐specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients

Lela Buckingham, L. Penfield Faber, Anthony Kim et al. · International Journal of Cancer · 2009 · 100 citations · Full text

Epigenetic Change, Pathology, Pten Promoter Hypermethylation +20

Comparison of solutol HS 15, cremophor EL and novel ethoxylated fatty acid surfactants as multidrug resistance modification agents

Lela Buckingham, R. Emanuele, Kathleen E. Clodfelter et al. · International Journal of Cancer · 1995 · 93 citations